Finance

Lists
002688:SHE
Jinhe Biotechnology Co Ltd
CNÂ¥5.33
+2.70%
(+0.14) 1D
Sep 4, 12:44:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002688...
Open
CNÂ¥5.20
High
CNÂ¥5.34
Low
CNÂ¥5.17
Mkt. cap
4.44B
Avg. vol.
10.10M
Volume
9.82M
Dividend
1.88%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 1, 2026
P/E ratio
158.21
52-wk high
CNÂ¥7.26
52-wk low
CNÂ¥4.58
EPS
CNÂ¥0.03
Shares outstanding
837.38M
No. of employees
3K
Open
CNÂ¥5.20
High
CNÂ¥5.34
Low
CNÂ¥5.17
Mkt. cap
4.44B
Avg. vol.
10.10M
Volume
9.82M
Dividend
1.88%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 1, 2026
P/E ratio
158.21
52-wk high
CNÂ¥7.26
52-wk low
CNÂ¥4.58
EPS
CNÂ¥0.03
Shares outstanding
837.38M
No. of employees
3K
About Jinhe Biotechnology Co Ltd
CEO-
Employees2.71K
FoundedMar 14, 1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
645.94M
841.90M
741.88M
705.79M
Cost of goods sold
437.99M
596.11M
477.57M
423.16M
Cost of revenue
437.99M
596.11M
477.57M
423.16M
Research and development expenses
39.13M
30.94M
19.44M
22.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.79M
126.30M
136.75M
129.73M
Operating expense
171.63M
177.94M
160.24M
150.20M
Total operating expenses
609.61M
774.05M
637.80M
573.36M
Operating income
36.33M
67.85M
104.08M
132.42M
Other non operating income
-3.52M
2.00M
-6.68M
-47.69M
EBT including unusual items
1.12M
-121.60M
76.97M
99.53M
EBT excluding unusual items
12.81M
42.27M
78.17M
103.97M
Income tax expense
4.29M
24.16M
13.63M
27.69M
Effective tax rate
382.50%
-19.87%
17.71%
27.83%
Other operating expenses
-13.29M
18.61M
2.17M
-291.06K
Net income
1.15M
-111.51M
62.30M
68.60M
Net profit margin
0.18%
-13.25%
8.40%
9.72%
Earnings per share
-
-
-
-
Interest and investment income
1.28M
5.19M
1.06M
20.29M
Interest expense
-20.94M
-24.00M
-20.29M
-1.05M
Net interest expenses
-19.66M
-18.80M
-19.22M
19.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
82.63M
125.26M
161.49M
195.30M
Gain or loss from assets sale
75.91K
2.73M
-
563.11K
AI content may include mistakes. Learn more
Google apps